BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25529918)

  • 1. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
    Szeliga M; Albrecht J
    Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.
    Szeliga M; Bogacińska-Karaś M; Różycka A; Hilgier W; Marquez J; Albrecht J
    Tumour Biol; 2014 Mar; 35(3):1855-62. PubMed ID: 24096582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.
    Majewska E; Rola R; Barczewska M; Marquez J; Albrecht J; Szeliga M
    J Physiol Pharmacol; 2017 Apr; 68(2):209-214. PubMed ID: 28614770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
    Martín-Rufián M; Nascimento-Gomes R; Higuero A; Crisma AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Cheng T; Lobo C; Segura JA; Alonso FJ; Szeliga M; Albrecht J; Curi R; Márquez J; Colquhoun A; Deberardinis RJ; Matés JM
    J Mol Med (Berl); 2014 Mar; 92(3):277-90. PubMed ID: 24276018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.
    de Los Santos-Jiménez J; Campos-Sandoval JA; Márquez-Torres C; Urbano-Polo N; Brøndegaard D; Martín-Rufián M; Lobo C; Peñalver A; Gómez-García MC; Martín-Campos J; Cardona C; Castilla L; da Costa Souza F; Cheng T; Segura JA; Alonso FJ; Curi R; Colquhoun A; DeBerardinis RJ; Márquez J; Matés JM
    J Biomed Sci; 2021 Feb; 28(1):14. PubMed ID: 33610185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
    Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
    Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
    Szeliga M; Ćwikła J; Obara-Michlewska M; Cichocki A; Albrecht J
    Exp Mol Pathol; 2016 Feb; 100(1):74-8. PubMed ID: 26581715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminases in brain: Multiple isoforms for many purposes.
    Campos-Sandoval JA; Martín-Rufián M; Cardona C; Lobo C; Peñalver A; Márquez J
    Neurochem Int; 2015 Sep; 88():1-5. PubMed ID: 25837287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation.
    López de la Oliva AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Martín-Rufián M; Sialana FJ; Castilla L; Bae N; Lobo C; Peñalver A; García-Frutos M; Carro D; Enrique V; Paz JC; Mirmira RG; Gutiérrez A; Alonso FJ; Segura JA; Matés JM; Lubec G; Márquez J
    Sci Rep; 2020 Feb; 10(1):2259. PubMed ID: 32042057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway.
    Majewska E; Márquez J; Albrecht J; Szeliga M
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669455
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
    Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
    J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
    Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
    Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases.
    Szeliga M; Obara-Michlewska M
    Neurochem Int; 2009; 55(1-3):71-5. PubMed ID: 19428809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
    Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
    Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells.
    Szeliga M; Obara-Michlewska M; Matyja E; Łazarczyk M; Lobo C; Hilgier W; Alonso FJ; Márquez J; Albrecht J
    Glia; 2009 Jul; 57(9):1014-23. PubMed ID: 19062176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and activation mechanism of the human liver-type glutaminase GLS2.
    Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
    Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLS2 is protumorigenic in breast cancers.
    Dias MM; Adamoski D; Dos Reis LM; Ascenção CFR; de Oliveira KRS; Mafra ACP; da Silva Bastos AC; Quintero M; de G Cassago C; Ferreira IM; Fidelis CHV; Rocco SA; Bajgelman MC; Stine Z; Berindan-Neagoe I; Calin GA; Ambrosio ALB; Dias SMG
    Oncogene; 2020 Jan; 39(3):690-702. PubMed ID: 31541193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Gls and Gls2 glutaminase isoforms in astrocytes.
    Cardona C; Sánchez-Mejías E; Dávila JC; Martín-Rufián M; Campos-Sandoval JA; Vitorica J; Alonso FJ; Matés JM; Segura JA; Norenberg MD; Rama Rao KV; Jayakumar AR; Gutiérrez A; Márquez J
    Glia; 2015 Mar; 63(3):365-82. PubMed ID: 25297978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
    Liu Z; Wang J; Li Y; Fan J; Chen L; Xu R
    Tumour Biol; 2017 Feb; 39(2):1010428317691429. PubMed ID: 28218035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer.
    Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA; Alonso FJ; Márquez J
    Curr Mol Med; 2013 May; 13(4):514-34. PubMed ID: 22934847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.